Annual report pursuant to Section 13 and 15(d)

Accrued Expenses - Schedule of Accrued Expenses (Details)

v3.19.1
Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Payables and Accruals [Abstract]    
Accrued clinical operations and trials costs $ 4,914,881 $ 2,003,799
Accrued product development costs 2,222,093 1,255,439
Accrued compensation 2,253,621 1,335,672
Accrued other 460,596 146,609
Total $ 9,851,191 $ 4,741,519